P2RY12 and atrial fibrillation: Our survey demonstrated that the majority of cardiologists used triple therapy (NOAC + dual antiplatelet [aspirin and P2Y12 inhibitor]), followed by NOAC + single antiplatelet for managing patients with AF and ACS or undergoing PCI in line with the available guidelines.